港股異動丨匯量科技漲超6%創近一年新高 躋身AppsFlyer全球第六 超越蘋果
格隆匯4月15日丨匯量科技(01860.HK)近日走勢連升,3日累計漲14%。現報4.3港元創近一年新高,漲6.17%,暫成交1588萬港元,最新總市值66億港元。匯量科技躋身全球前十陣營的中國廣告平台,甚至超越了蘋果。中信證券點評稱,公司躋身AppsFlyer全球第六,維持“買入”評級。躋身AppsFlyer全球榜單第一批隊,使得業務飛輪持續強化,已構建起全球競爭力。作為“全球新經濟智能移動廣告第一股”,匯量科技的業績證明了這一發展趨勢。2019年公司營收達34.9億元人民幣,同比增長15.1%,利潤為3.6億元人民幣,實現19.5%的大幅提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.